Stay updated with breaking news from Nasdaq Naut. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vanguard Capital Wealth Advisors decreased its stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 13.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,000 shares of the company’s stock after selling 6,000 shares during the period. Vanguard Capital […]
Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively...
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...
Vanguard Capital Wealth Advisors trimmed its position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 21.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 59,000 shares of the company’s stock after selling 16,500 shares during the quarter. Vanguard Capital Wealth Advisors’ holdings […]
Clarius Group LLC lifted its position in shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Get Rating) by 1.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 597,972 shares of the company’s stock after purchasing an additional 10,667 shares […]